STARD13 Antikörper (AA 544-573)

Produktnummer ABIN1881846

Produktdetails anti-STARD13 Antikörper

Target: STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))

Bindungsspezifität: AA 544-573

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser STARD13 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen: This STARD13 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 544-573 amino acids from the Central region of human STARD13.

Klon: RB40830

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: WB: 1:1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Haltbarkeit: 6 months

Referenzen für anti-STARD13 Antikörper (ABIN1881846)

Zhang, Wang, Hu: "STARD13 promotes hepatocellular carcinoma apoptosis by acting as a ceRNA for Fas." in: Biotechnology letters, Vol. 39, Issue 2, pp. 207-217, (2017) (PubMed).

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Talmud, Drenos, Shah, Shah, Palmen, Verzilli, Gaunt, Pallas, Lovering, Li, Casas, Sofat, Kumari, Rodriguez, Johnson, Newhouse, Dominiczak, Samani, Caulfield, Sever, Stanton, Shields, Padmanabhan et al.: "Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. ..." in: American journal of human genetics, Vol. 85, Issue 5, pp. 628-42, (2009) (PubMed).

Details zu STARD13

Target: STARD13 (StAR-Related Lipid Transfer (START) Domain Containing 13 (STARD13))

Andere Bezeichnung: STARD13 (STARD13 Produkte)

Synonyme: ARHGAP37 antikoerper, DLC2 antikoerper, GT650 antikoerper, LINC00464 antikoerper, RGD1564816 antikoerper, StAR related lipid transfer domain containing 13 antikoerper, StAR-related lipid transfer (START) domain containing 13 antikoerper, StAR-related lipid transfer domain containing 13 antikoerper, STARD13 antikoerper, Stard13 antikoerper

Hintergrund: This gene encodes a protein that contains a sterile alpha motif domain in the N-terminus, an ATP/GTP-binding motif, a GTPase-activating protein domain, and a STAR-related lipid transfer domain in the C-terminus. The gene is located in a region of chromosome 13 that has loss of heterozygosity in hepatic cancer. At least three alternatively spliced transcript variants have been described for this gene.

Molekulargewicht: 124967

NCBI Accession: NP_001230395, NP_001230403, NP_001230405, NP_443083, NP_821074, NP_821075

UniProt: Q9Y3M8